Italy Clinical Trial Patient Recruitment Services Market Size & Outlook
Italy clinical trial patient recruitment services market, 2018-2030 (US$M)
Related Markets
Italy clinical trial patient recruitment services market highlights
- The Italy clinical trial patient recruitment services market generated a revenue of USD 24.2 million in 2023 and is expected to reach USD 43.7 million by 2030.
- The Italy market is expected to grow at a CAGR of 8.8% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Clinical trial patient recruitment services market data book summary
| Market revenue in 2023 | USD 24.2 million |
| Market revenue in 2030 | USD 43.7 million |
| Growth rate | 8.8% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
| Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
Other key industry trends
- In terms of revenue, Italy accounted for 2.7% of the global clinical trial patient recruitment services market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany clinical trial patient recruitment services market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 43.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Patient Recruitment Services Market Scope
Clinical Trial Patient Recruitment Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy clinical trial patient recruitment services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.44% in 2023. Horizon Databook has segmented the Italy clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical sector remains a major development driver for the Italian economy. In 2018, Farmindustria reported that around 20% of clinical trials in Europe are conducted in Italy, and a total investment of USD 800.7 million has been made by sponsors.
The increase in drug demand and the simplification of the approval process for clinical trials on novel medicines are expected to promote the demand for clinical trial patient recruitment services in the country.
The recent reemergence of infectious diseases, such as COVID-19, has boosted investments in developing new treatments. Such actions are likely to benefit the Italian market.
Reasons to subscribe to Italy clinical trial patient recruitment services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy clinical trial patient recruitment services market databook
-
Our clientele includes a mix of clinical trial patient recruitment services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into Italy clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy clinical trial patient recruitment services market size, by phase, 2018-2030 (US$M)
Italy Clinical Trial Patient Recruitment Services Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
